ALTANA Pharma

Cities in Canada

0 studies enrolling now · 3 studies all time

What they study most

COPD, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, COPD

Studies at this site

• OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111) — Completed
• Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110) — Completed
• The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121) — Completed